Loading...
ACTR-03. A FEASIBILITY TRIAL OF THE MODIFIED ATKINS DIET AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
BACKGROUND: We report results of a feasibility trial of the modified Atkins diet (MAD), a form of ketogenic diet (KD), combined with bevacizumab (Bev) for recurrent GBM. The rationale for a KD to treat GBM includes the reduction of glucose availability to this highly glycolytic tumor, reduction of a...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216153/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.040 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|